Oxford Global’s 9th Annual Formulation & Respiratory Drug Delivery Congress, 25 – 26 May 2023, London, UK will be attended by over 350 visionary leaders to network about the latest innovations in the field. With a revamped agenda, visionary leaders will be looking at novel approaches to both small & large molecule formulation development, exploring new drug delivery systems and stability & characterisation updates.   

The event will be taking a deep dive into the following main themes:  

• Day 1 Track 1: Small Molecule Drug Formulation 
• Day 1 Track 2: Biologics Drug Delivery 
• Day 1 Track 3: Bioanalysis: Stability, Characterisation, Developability 
• Day 2 Track 1: Small Molecule Drug Delivery 
• Day 2 Track 2: Multi Specific Antibodies, Cell Engagers & Other New Modalities 

Key Speakers Include:  

• Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG 
• Werngard Czechtizky, Executive Director, Head of Medicinal Chemistry, AstraZeneca  
• Ben Van Hove, Scientific Director, Janssen 
• Norbert Lauber, Director, Autoinjectors & Pump Systems, Novartis 
• Pawel Stasiak, Pharma Development Director, Zentiva  
• Yogeshwar Bachhav, Associate Director, AiCuris Anti-infective Cures AG Germany 
• Kathy Wang, Associate Director, AstraZeneca  

Featuring a series of dedicated interactive sessions:   

• Panel Discussion: Developability Assessment 
• Panel Discussion: Small Molecule Formulation – Future Developments, Complexity & Novel Technologies 
• Workshop: Oral Delivery Of Biologics 
• Roundtable: Sustainability In Formulation Development 
• Roundtable: Implementing Novel Bioanalytical Technique 
• Roundtable: Advancing Biologics & New Modalities Drug Formulation  

Co-located with the Inhalation & Respiratory Drug Delivery Congress. More information contact marketing@oxfordglobal.co.uk.